SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062471
Filing Date
2023-11-13
Accepted
2023-11-13 08:08:26
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-20230930.htm   iXBRL 10-Q 2332436
2 EX-31.1 rapt-ex31_1.htm EX-31.1 18702
3 EX-31.2 rapt-ex31_2.htm EX-31.2 18727
4 EX-32.1 rapt-ex32_1.htm EX-32.1 20105
  Complete submission text file 0000950170-23-062471.txt   7359775

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rapt-20230930_pre.xml EX-101.PRE 244616
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rapt-20230930.xsd EX-101.SCH 40877
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rapt-20230930_cal.xml EX-101.CAL 46550
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rapt-20230930_def.xml EX-101.DEF 142891
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rapt-20230930_lab.xml EX-101.LAB 339121
54 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20230930_htm.xml XML 1247884
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 231395282
SIC: 2834 Pharmaceutical Preparations